Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kedrion S.p.A.

Clinical trials sponsored by Kedrion S.p.A., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New IVIg therapy aims to boost platelets in chronic ITP patients Results expected Dec 2026 (estimated)
New antibody therapy aims to shield kids with rare immune disease from deadly infections Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New antibody infusion shows promise for immune deficiency patients

Disease control Completed

This study tested a new intravenous immunoglobulin (IVIg) treatment called Kedrion IVIg 10% in 47 people with primary immunodeficiency, a condition where the immune system cannot make enough antibodies. The goal was to see if regular infusions of this antibody therapy could preve…

Phase 3 • Sponsor: Kedrion S.p.A. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC